Trevi Therapeutics, Inc. (TRVI) stock
TRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.51+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.92BP/E –Yield –
Trevi Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Trevi Therapeutics's market cap was $2.11B on Nov 11, 2026, against $1.69B a year earlier. Over the last 5 years it ranged from $11.83M to $2.39B, with a median of $213.78M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.11B | +31.4% |
| 2025 | Dec 31, 2025 | $1.61B | +416.4% |
| 2024 | Dec 31, 2024 | $310.87M | +263.3% |
| 2023 | Dec 29, 2023 | $85.57M | -24.0% |
| 2022 | Dec 30, 2022 | $112.56M | +675.9% |
| 2021 | Dec 31, 2021 | $14.51M | -67.3% |
| 2020 | Dec 31, 2020 | $44.34M | -33.7% |
| 2019 | Dec 31, 2019 | $66.88M | – |
See a number that looks wrong?